Poliomyelitis Survivors in the Time of a COVID-19 pandemic (SARS CoV-2)

Authors

DOI:

https://doi.org/10.33448/rsd-v11i7.30014

Keywords:

Poliomyelitis; Postpoliomyelitis Syndrome; COVID-19; Quarantine.

Abstract

Acute Anterior Poliomyelitis left sequelae on survivors, making them need continuous treatments, making them possibly vulnerable in the COVID-19 Pandemic. This study aims to analyze the prevalence of risk factors for contracting COVID-19 as well as developing the severe form among patients with Poliomyelitis Sequelae and Post Poliomyelitis Syndrome (PPS). An epidemiological study was carried out with an online questionnaire addressing epidemiological, physical and psycho-emotional health issues. For analysis, the Chi-square test was used. A total of 383 responses were obtained, divided into: Sequelae of Poliomyelitis (GP-49%;n=190) and PPS (GSPP-50.4%;n=193). Female gender and the age group 50-59 years were more prevalent in both groups. The most frequent involvements were monoparesis (38.9%GP; 21.7%GSPP), paraparesis (18.9%GP) and tetraparesis (16.6%GSPP). As for comorbidities, 37.4%GP and 37.3%GSPP reported Hypercholesterolemia; 42.6% GP and 47.1% GSPP Hypertension and 19.5% GP and 14.5% GSPP Diabetes. In the physical aspects, 57.9% (GP) and 65.8% (GSPP) reported worsening in quarantine and 19.7% (GSPP) and 7.9% (GP) need external help in activities. Poliomyelitis survivors are more vulnerable to contracting COVID-19 as well as manifesting the severe form of the disease due to their previous physical conditions and the comorbidities they present.

References

Boyle, C. A., Fox, M. H., Havercamp, S. M., & Zubler, J. (2020). The public health response to the COVID-19 pandemic for people with disabilities. Disability and health journal, 13(3), 100943. https://doi.org/10.1016/j.dhjo.2020.100943

BRASIL. (2020). Decreto 64881, de 23 de março de 2020. Decreta quarentena no Estado de São Paulo, no contexto da Pandemia do COVID-19 (Novo Coronavírus), e dá providências complementares. Diário Oficial do Estado de São Paulo, São Paulo, SP. https://www.al.sp.gov.br/repositorio/legislacao/decreto/2020/decreto-64881-22.03.2020.html

Brito, S. B. P., Braga, I. O., Cunha, C. C., & Takenami, I. (2020). Immunopathological mechanisms involved in SARS-CoV-2 infection. Brazilian Journal of Pathology and Laboratory Medicine, 56(1), 1-10. https://www.jbpml.org.br/pt/article/1765/

Conde, M. T., Oliveira, A. S., Quadros, A. A., Moreira, G. A., Silva, H. C., Pereira, R. D., e Silva, T. M., Tufik, S., & Waldman, E. A. (2009). Post-polio syndrome: epidemiologic and prognostic aspects in Brazil. Acta neurologica Scandinavica, 120(3), 191–197. https://doi.org/10.1111/j.1600-0404.2008.01142.x

Divisão de Doenças de Transmissão Hídrica e Alimentares & Centro de Vigilancia Epidemiológica “Alexandre Vranjac” & Coordenadoria de Controle de Doenças & Secretaria de Estado da Saúde de São Paulo. (2006). Síndrome pós-poliomielite. Informes Técnicos Institucionais. Revista Saúde Pública, 40(5). https://doi.org/10.1590/S0034-89102006000600029

Fang, X., Li, S., Yu, H., Wang, P., Zhang, Y., Chen, Z., Li, Y., Cheng, L., Li, W., Jia, H., & Ma, X. (2020). Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging, 12(13), 12493–12503. https://doi.org/10.18632/aging.103579

Gao, Y. D., Ding, M., Dong, X., Zhang, J. J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y. L., Fu, W., Li, W., Liang, H. L., Cao, Y. Y., Yan, Q., Cao, C., Gao, H. Y., Brüggen, M. C., van de Veen, W., Sokolowska, M., Akdis, M., & Akdis, C. A. (2021). Risk factors for severe and critically ill COVID-19 patients: A review. Allergy, 76(2), 428–455. https://doi.org/10.1111/all.14657

Grasselli, G., Greco, M., Zanella, A., Albano, G., Antonelli, M., Bellani, G., Bonanomi, E., Cabrini, L., Carlesso, E., Castelli, G., Cattaneo, S., Cereda, D., Colombo, S., Coluccello, A., Crescini, G., Forastieri Molinari, A., Foti, G., Fumagalli, R., Iotti, G. A., Langer, T., … COVID-19 Lombardy ICU Network (2020). Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA internal medicine, 180(10), 1345–1355. https://doi.org/10.1001/jamainternmed.2020.3539

Guidon, A. C., & Amato, A. A. (2020). COVID-19 and neuromuscular disorders. Neurology, 94(22), 959–969. https://doi.org/10.1212/WNL.0000000000009566

Hajjar, L. A., Costa, I., Rizk, S. I., Biselli, B., Gomes, B. R., Bittar, C. S., de Oliveira, G. Q., de Almeida, J. P., de Oliveira Bello, M. V., Garzillo, C., Leme, A. C., Elena, M., Val, F., de Almeida Lopes, M., Lacerda, M., Ramires, J., Kalil Filho, R., Teboul, J. L., & Landoni, G. (2021). Intensive care management of patients with COVID-19: a practical approach. Annals of intensive care, 11(1), 36. https://doi.org/10.1186/s13613-021-00820-w

Hawryluck, L., Gold, W. L., Robinson, S., Pogorski, S., Galea, S., & Styra, R. (2004). SARS control and psychological effects of quarantine, Toronto, Canada. Emerging infectious diseases, 10(7), 1206–1212. https://doi.org/10.3201/eid1007.030703

Instituto Brasileiro de Geografia e Estatística. (2020a). Pesquisa Nacional de Saúde 2019: Percepção do estado de saúde, estilos de vida, doenças crônicas e saúde bucal. Brasil. Ministério da Saúde, Ministério da Economia. https://biblioteca.ibge.gov.br/visualizacao/livros/liv101764.pdf

Instituto Brasileiro de Geografia e Estatística. (2020b). Pesquisa Nacional de Saúde 2019: Atenção Primária à Saúde e informações antropométricas. Brasil. Ministério da Saúde, Ministério da Economia. https://biblioteca.ibge.gov.br/visualizacao/livros/liv101758.pdf

Leung C. (2020). Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China. Mechanisms of ageing and development, 188, 111255. https://doi.org/10.1016/j.mad.2020.111255

Meyerowitz, E. A., Richterman, A., Gandhi, R. T., & Sax, P. E. (2021). Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Annals of internal medicine, 174(1), 69–79. https://doi.org/10.7326/M20-5008

Motta, M. P. (2017). Efeito Terapêutico do uso da L-carnitina + Piracetam na fadiga e na força muscular de Pacientes com Síndrome Pós-poliomielite (SPP): Estudo Clínico Randomizado, Duplo-cego, controlado com Placebo [Dissertação de mestrado não publicada]. Universidade Federal de São Paulo.

Motta, M. P., Quadros, A. A. J., Cont,i M. de S. B., Falci, M. & Oliveira, A. S. B. (2020). L-carnitine+piracetam for fatigue and muscular strength of patients with post-poliomyelitis. International Physical Medicine & Rehabilitation Journal, 5(6), 220–228. https://doi.org/10.15406/ipmrj.2020.05.00261

Neves, M. A. O., Mello, M. P., Reis, J. P. B., Rei, A. M., Antonioli, R. S., Nascimento, O. J. M., Freitas, M. R. G. (2007). A síndrome pós-polio e o processo de reabilitação motora: relato de caso. Revista Neurociências, 15(4), 321–325. https://doi.org/10.34024/rnc.2007.v15.8680

Nickel, C. H., Rueegg, M., Pargger, H., & Bingisser, R. (2020). Age, comorbidity, frailty status: effects on disposition and resource allocation during the COVID-19 pandemic. Swiss medical weekly, 150, w20269. https://doi.org/10.4414/smw.2020.20269

Nollet, F., Beelen, A., Sargeant, A. J., de Visser, M., Lankhorst, G. J., & de Jong, B. A. (2001). Submaximal exercise capacity and maximal power output in polio subjects. Archives of physical medicine and rehabilitation, 82(12), 1678–1685. https://doi.org/10.1053/apmr.2001.27390

Oliveira, A. S. B. & Quadros, A. A. J. (2008). Síndrome Pós-Poliomielite (SPP) - Orientações para profissionais de saúde. Secretaria de Estado da Saúde de São Paulo. http://www.saude.sp.gov.br/resources/ses/perfil/profissional-da-saude/homepage//sindrome_pos_poliomielite_.pdf

Oliveira, A. S. B. & Quadros, A. A. J. (2009). Síndrome Pós-Poliomielite (SPP) - Orientações para profissionais de Saúde (2nd ed.). Ministério da Saúde. UNIFESP.

Oliveira, A. S. B., Quadros, A. A. J., Silva, T. M., Motta, M., Helou, A.S., Leite, F. M., Gomes, E. A. (2014). Doenças do Neurônio Motor: Poliomielite Anterior Aguda/ Síndrome Pós Poliomielite. In: Oliveira, A. S. B., Oda, A. D. Reabilitação em Doenças Neuromusculares: Guia Terapêutico Prático (1rst ed.). Editora Ateneu.

Onder, G., Rezza, G., & Brusaferro, S. (2020). Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA, 323(18), 1775–1776. https://doi.org/10.1001/jama.2020.4683

Orsini, M., Lopes, A. J., Guimarães, F. S., Freitas, M. R., Nascimento, O. J., Anna, M., Junior, Moreira, P., Filho, Fiorelli, S., Ferreira, A. C., Pupe, C., Bastos, V. H., Pessoa, B., Nogueira, C. B., Schmidt, B., Souza, O. G., Davidovich, E. R., Oliveira, A. S., & Ribeiro, P. (2016). Currents issues in cardiorespiratory care of patients with post-polio syndrome. Arquivos de neuro-psiquiatria, 74(7), 574–579. https://doi.org/10.1590/0004-282X20160072

Parohan, M., Yaghoubi, S., Seraji, A., Javanbakht, M. H., Sarraf, P., & Djalali, M. (2020). Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The aging male : the official journal of the International Society for the Study of the Aging Male, 23(5), 1416–1424. https://doi.org/10.1080/13685538.2020.1774748

Pereira, R. D., Silva, T. M., Quadros, A. A., Orsini, M., Schmidt, B., Silva, H. C., & Oliveira, A. S. (2017). Assessment of energy expenditure in individuals with post-poliomyelitis syndrome. Arquivos de neuro-psiquiatria, 75(3), 147–152. https://doi.org/10.1590/0004-282X20170013

Quadros, A. A., Conde, M. T., Marin, L. F., Silva, H. C., Silva, T. M., Paula, M. B., Pereira, R. D., Ramos, P. E., Abe, G., & Oliveira, A. S. (2012). Frequency and clinical manifestations of post-poliomyelitis syndrome in a Brazilian tertiary care center. Arquivos de neuro-psiquiatria, 70(8), 571–573. https://doi.org/10.1590/s0004-282x2012000800002

Reddy, R. K., Charles, W. N., Sklavounos, A., Dutt, A., Seed, P. T., & Khajuria, A. (2021). The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. Journal of medical virology, 93(2), 1045–1056. https://doi.org/10.1002/jmv.26389

Reichenberger, V., Alburquerque, M., David, R. B., Ramos, V. D., Lyra, T. M., Brito, C., Köptcke, L. S., & Kuper, H. (2020). The challenge of including people with disabilities in the strategy to address the COVID-19 pandemic in Brazil. O desafio da inclusão de pessoas com deficiência na estratégia de enfrentamento à pandemia de COVID-19 no Brasil. Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil, 29(5), e2020770. https://doi.org/10.1590/S1679-49742020000500023

Shen, N., Zhu, Y., Wang, X., Peng, J., Liu, W., Wang, F., Lu, Y., Cheng, L., & Sun, Z. (2020). Characteristics and diagnosis rate of 5630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China. JCI insight, 5(10), e137662. https://doi.org/10.1172/jci.insight.137662

Sociedade Brasileira de Cardiologia. (2013). V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arquivos Brasileiros de Cardiologia. http://dx.doi.org/10.5935/abc.2013S010

World Health Organization. (2013). Guidance Note on Disability and Emergency Risk Management for Health. https://www.who.int/publications/i/item/guidance-note-on-disability-and-emergency-risk-management-for-health

World Health Organization. (2020, January). WHO Director-General’s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus-(2019-ncov)

Published

04/06/2022

How to Cite

NOGUEIRA, J. A. A. .; MOTTA, M. P.; QUADROS, A. A. J.; NEVES, M. A. O. .; FAVARO, V. M. .; FONTES, S. V.; FAVERO, F. M.; OLIVEIRA, A. S. B. Poliomyelitis Survivors in the Time of a COVID-19 pandemic (SARS CoV-2). Research, Society and Development, [S. l.], v. 11, n. 7, p. e54811730014, 2022. DOI: 10.33448/rsd-v11i7.30014. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/30014. Acesso em: 29 feb. 2024.

Issue

Section

Health Sciences